0000892251-26-000043.txt : 20260312
0000892251-26-000043.hdr.sgml : 20260312
20260312103006
ACCESSION NUMBER: 0000892251-26-000043
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20260312
DATE AS OF CHANGE: 20260312
EFFECTIVENESS DATE: 20260312
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioSolution Designs, Inc.
CENTRAL INDEX KEY: 0002110022
ORGANIZATION NAME:
EIN: 365031957
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-576280
FILM NUMBER: 26746142
BUSINESS ADDRESS:
STREET 1: 4539 METROPOLITAN CT.
CITY: FREDERICK
STATE: MD
ZIP: 21704
BUSINESS PHONE: 561-325-5953
MAIL ADDRESS:
STREET 1: 4539 METROPOLITAN CT.
CITY: FREDERICK
STATE: MD
ZIP: 21704
D
1
primary_doc.xml
X0708
D
LIVE
0002110022
BioSolution Designs, Inc.
4539 METROPOLITAN CT.
FREDERICK
MD
MARYLAND
21704
561-325-5953
DELAWARE
None
None
Corporation
true
2022
Thomas
Reed
4539 Metropolitan Ct.
Frederick
MD
MARYLAND
21704
Executive Officer
Director
CEO
John
Maslowski
4539 Metropolitan Ct.
Frederick
MD
MARYLAND
21704
Director
Daniel
Shelly
4539 Metropolitan Ct
Frederick
MD
MARYLAND
21704
Director
Biotechnology
Decline to Disclose
- 06b
false
2026-03-09
false
true
false
10000
1500000
705000
795000
false
9
0
0
76000
true
Approximately $76,000 of the gross proceeds will be paid over time to the CEO for repayment of a loan made to the company by the CEO.
false
BioSolution Designs, Inc.
/s/ Thomas Reed
Thomas Reed
CEO
2026-03-12